TIVIC HEALTH SY.DL -,0001 Aktie

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company developing treatments that stimulate immune pathways to treat disease, today announced it has completed all study visits in the Optimization Study for its patent pending, non-invasive cervical vagus nerve stimulation (ncVNS) device. Initial findings reinforce the importance of personalization for therapeutic efficacy. Tivic expects to release the study results later this year.» Mehr auf businesswire.com

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today its Virtual Annual General Meeting of Shareholders will be held on Monday, June 30, 2025 at 1:00 PM, Pacific Time | 4:00 PM Eastern Time. The Company has adopted a virtual format for its Annual Meeting to provide a consistent and convenient experience for all stockholders regardless of their location. In lieu of a live Q&A session, stockholders can submit questio.» Mehr auf businesswire.com

Tivic Health Systems Inc. (NASDAQ:TIVC ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Jennifer Ernst – Chief Executive Officer Lisa Wolf – Interim Chief Financial Officer Michael Handley – Chief Operating Officer and President-Tivic Biopharma Division Conference Call Participants Operator Welcome to Tivic Health Systems First Quarter 2025 Financial Results and Operational Update Conference Call. This call has been prerecorded, and the questions you have submitted in advance will be answered following the prepared remarks.» Mehr auf seekingalpha.com